Pharmacokinetics of the novel recombinant plasminogen activator BM 06.022 in rats, dogs, and non-human primates
- 31 January 1992
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 6 (1) , 39-43
- https://doi.org/10.1016/0268-9499(92)90046-k
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cellsThrombosis Research, 1990
- Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis.Circulation, 1990
- Pharmacokinetics and Haemostatic Status During Consecutive Infusions of Recom binant Tissue-Type Plasminogen Activator in Patients with Acute Myocardial InfarctionThrombosis and Haemostasis, 1989
- Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjectsClinical Pharmacology & Therapeutics, 1989